<DOC>
	<DOCNO>NCT00982332</DOCNO>
	<brief_summary>The study examine efficacy single intramuscular injection betamethasone dipropionate/betamethasone sodium phosphate dose 20mg/8mg ( injection volume 4 ml ) induction therapy patient polymyalgia rheumatica . Twenty patient randomized receive injection betamethasone placebo ( isotonic NaCl solution ) immediately diagnosis . Both group receive standard-of-care steroid therapy , start 10 mg prednisone every day ( qd ) , taper 2.5 mg monthly disease active ( schedule monthly follow-up rheumatologist ) . Primary outcome measure : total cumulative dose glucocorticosteroids disease duration .</brief_summary>
	<brief_title>Efficacy Micro-Pulse Steroid Therapy Induction Therapy Patients With Polymyalgia Rheumatica</brief_title>
	<detailed_description />
	<mesh_term>Polymyalgia Rheumatica</mesh_term>
	<mesh_term>Giant Cell Arteritis</mesh_term>
	<mesh_term>Betamethasone benzoate</mesh_term>
	<mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
	<mesh_term>Betamethasone</mesh_term>
	<mesh_term>Betamethasone Valerate</mesh_term>
	<mesh_term>Betamethasone sodium phosphate</mesh_term>
	<criteria>clinical diagnosis polymyalgia rheumatica decompensated diabetes mellitus decompensated arterial hypertension</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>polymyalgia rheumatica</keyword>
</DOC>